BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Healthtrust
McKinsey
Mallinckrodt
Johnson and Johnson
Citi
Moodys
Dow
Daiichi Sankyo

Generated: January 17, 2018

DrugPatentWatch Database Preview

Doxapram hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxapram hydrochloride and what is the scope of doxapram hydrochloride freedom to operate?

Doxapram hydrochloride
is the generic ingredient in two branded drugs marketed by West-ward Pharms Int, Athenex Inc, and Watson Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for doxapram hydrochloride. One supplier is listed for this compound.
Pharmacology for doxapram hydrochloride
Medical Subject Heading (MeSH) Categories for doxapram hydrochloride

US Patents and Regulatory Information for doxapram hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DOPRAM doxapram hydrochloride INJECTABLE;INJECTION 014879-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Athenex Inc DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 076266-001 Jan 10, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs DOXAPRAM HYDROCHLORIDE doxapram hydrochloride INJECTABLE;INJECTION 073529-001 Jan 30, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Medtronic
US Department of Justice
Fuji
Accenture
Citi
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot